Cargando…
Screening of Heteroaromatic Scaffolds against Cystathionine Beta-Synthase Enables Identification of Substituted Pyrazolo[3,4-c]Pyridines as Potent and Selective Orthosteric Inhibitors
Cystathionine β-synthase (CBS) is a key enzyme in the production of the signaling molecule hydrogen sulfide, deregulation of which is known to contribute to a range of serious pathological states. Involvement of hydrogen sulfide in pathways of paramount importance for cellular homeostasis renders CB...
Autores principales: | Fantel, Anna-Maria, Myrianthopoulos, Vassilios, Georgoulis, Anastasios, Lougiakis, Nikolaos, Zantza, Iliana, Lamprinidis, George, Augsburger, Fiona, Marakos, Panagiotis, Vorgias, Constantinos E., Szabo, Csaba, Pouli, Nicole, Papapetropoulos, Andreas, Mikros, Emmanuel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7465669/ https://www.ncbi.nlm.nih.gov/pubmed/32824311 http://dx.doi.org/10.3390/molecules25163739 |
Ejemplares similares
-
Discovery of New 1,4,6-Trisubstituted-1H-pyrazolo[3,4-b]pyridines with Anti-Tumor Efficacy in Mouse Model of Breast Cancer †
por: Georgiou, Maria, et al.
Publicado: (2023) -
Discovery of a High Affinity Adenosine A(1)/A(3) Receptor Antagonist with a Novel 7-Amino-pyrazolo[3,4-d]pyridazine Scaffold
por: Suchankova, Anna, et al.
Publicado: (2022) -
Synthesis of New Imidazopyridine Nucleoside Derivatives Designed as Maribavir Analogues
por: Papadakis, Georgios, et al.
Publicado: (2020) -
Novel Substituted Purine Isosteres: Synthesis, Structure-Activity Relationships and Cytotoxic Activity Evaluation
por: Dimitrakis, Spyridon, et al.
Publicado: (2021) -
Screening of a composite library of clinically used drugs and well-characterized pharmacological compounds for cystathionine β-synthase inhibition identifies benserazide as a drug potentially suitable for repurposing for the experimental therapy of colon cancer
por: Druzhyna, Nadiya, et al.
Publicado: (2016)